US FDA approves Abeona's skin disorder therapy
29/04/2025 11:02
April 29 (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Abeona Therapeutics' ABEO.O gene therapy for a rare skin disorder. (Reporting by Kamal Choudhury and Sneha S K in Bengaluru; Editing by Tasim Zahid) ((Kamal.Choudhury@thomsonreuters.com;))
Recent news on Abeona Therapeutics
See all newsBrief: Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Ultragenyx rises after FDA nod for rare disorder drug
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports